Heron’s pain drug succeeds in phase 3 bunionectomy and hernia repair trials

This article was originally published here

Heron Therapeutics’ pain drug HTX-011 has succeeded in two phase 3 trials in patients undergoing bunionectomy and hernia repair by meeting all their primary and key secondary points.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply